Myogel is a trade name for a human-based extracellular matrix used in cancer research to provide a 3D cell culture environment for cancer cells. Unlike other synthesized matrices such as matrigel which originated from micesarcoma, myogel is extracted from a human benign tumor tissue called leiomyoma. Myogel was developed in Tuula Salo's lab at the University of Oulu. The idea started in 2009 by culturing cancer cells on myoma discs.[1] Later in 2015, these myoma tissues were processed following matrigel receipt, to extract a gel form called Myogel.[2] Myogel was compared with matrigel and found to be superior in term of enhancing cancer cells proliferation, migration and invasion.[2]